Life science distributor expands into the Czech Republic and strengthens diagnostics capabilities through acquisition

Company news

Life science distributor expands into the Czech Republic and strengthens diagnostics capabilities through acquisition

18 Nov, 2026

Europa Biosite is pleased to announce the acquisition of MEDISTA spol. s r.o., a specialist distributor of diagnostics and laboratory technology in the Czech Republic. The acquisition is subject to customary regulatory approvals.

The addition of MEDISTA marks another important milestone in Europa Biosite’s growth, marking the group’s entry into the Czech Republic for the first time, continuing its expansion across Europe and significantly strengthening its capabilities in diagnostics. MEDISTA brings valuable diagnostics knowledge and experience to Europa Biosite, complementing the group’s established life science distribution businesses across Europe and North America.

MEDISTA will retain the local expertise, customer focus and relationships that have been central to its success. MEDISTA’s directors, Jan Kadlec and Alexandra Kadlecová, will continue in their respective roles. Kadlec, CEO of MEDISTA, will also join the Europa Biosite group leadership team, bringing his knowledge and experience of the diagnostics market to the wider group.

Claudia Berrón, CEO of Europa Biosite, commented:

“I am pleased to welcome the MEDISTA team to Europa Biosite. MEDISTA is a strong addition to Europa Biosite, bringing valuable diagnostics expertise, strong customer and supplier relationships and deep knowledge of the Czech market. I look forward to working together to support customers, suppliers, and accelerate our continued growth.”

Kadlec commented:

“Joining Europa Biosite represents an exciting new chapter for MEDISTA. Becoming part of a wider international Group gives us the opportunity to build on our existing strengths while benefiting from the expertise, resources and network across Europa Biosite. Our commitment to customers, suppliers and partners remains unchanged, and I look forward to continuing to lead MEDISTA while contributing to the future development of Europa Biosite.”

The acquisition of MEDISTA is another important step in Europa Biosite’s strategy to build a leading European life science and diagnostics distribution group. By bringing together specialist businesses with established local market positions, technical expertise and strong customer and supplier relationships, Europa Biosite is building a powerful European platform that gives customers greater access to specialist products, knowledge and support, while providing suppliers with a high-performing route to market.

Europa Biosite has ambitious plans for further growth and will continue to actively pursue strategic acquisitions that expand its presence across Europe, strengthen its specialist capabilities and bring complementary businesses into the group.

Latest News

LMUK 51.7 Nov 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Vehicle-based methane detection system passes German suitability test
Explore more Arrow
Pollution Solutions Online
Large-scale liquefied biogas bunkering to become possible in the Port of Gothenburg in 2027
Explore more Arrow
Petro Online
Confidence in Every Drop. Precision in Every Test.
Explore more Arrow
Chromatography Today
High-load peptide purification
Explore more Arrow